| |
| |
|
| Insider
Information: |
Kerins Patrick J |
| Relationship: |
10% Owner |
| City: |
Baltimore |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
36 |
|
| Direct
Shares |
2,400,049 |
|
|
Indirect Shares
|
216,112,072 |
|
|
| Direct
Value |
$2,666,741 |
|
|
|
Indirect Value
|
$660,561,111 |
|
|
| Total
Shares |
218,512,121 |
|
|
| Total
Value |
$663,227,853 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -59.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Hemosense Inc |
HEM |
10% Owner |
2006-12-12 |
1,772,151 |
|
0 |
Premium* |
|
|
Aryx Therapeutics Inc |
ARYX |
10% Owner |
|
0 |
2011-03-10 |
0 |
Premium* |
|
|
Echo Global Logistics Inc |
ECHO |
10% Owner |
2012-02-28 |
97 |
2012-02-28 |
0 |
Premium* |
|
|
Viracta Therapeutics Ord Shs |
VIRX |
10% Owner |
2010-06-30 |
0 |
2014-08-29 |
4,659,333 |
Premium* |
|
|
Groupon, Inc. |
GRPN |
10% Owner |
2013-09-13 |
7,944 |
2013-09-13 |
0 |
Premium* |
|
|
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2013-06-03 |
575 |
2013-06-03 |
0 |
Premium* |
|
|
Millennial Media Inc |
MM |
Director |
2015-10-22 |
15,625 |
2015-10-22 |
0 |
Premium* |
|
|
Tesaro, Inc. |
TSRO |
10% Owner |
2019-01-22 |
0 |
2019-01-22 |
0 |
Premium* |
|
|
Hyperion Therapeutics Inc |
HPTX |
10% Owner |
2015-05-07 |
0 |
2015-05-07 |
0 |
Premium* |
|
|
Workday, Inc. |
WDAY |
10% Owner |
2013-04-10 |
1,730 |
2013-04-10 |
0 |
Premium* |
|
|
Interleukin Genetics Inc |
ILIU |
10% Owner |
|
0 |
2016-07-29 |
55,418,811 |
Premium* |
|
|
Channeladvisor Corp |
ECOM |
Director |
2016-03-01 |
35,853 |
2015-12-14 |
0 |
Premium* |
|
|
Epizyme, Inc. |
EPZM |
10% Owner |
2016-01-12 |
651 |
2016-01-12 |
6,260,851 |
Premium* |
|
|
Care.com Inc |
CRCM |
10% Owner |
2017-11-06 |
504 |
2017-11-06 |
0 |
Premium* |
|
|
Roka Bioscience, Inc. |
ROKA |
10% Owner |
|
0 |
2014-07-22 |
3,216,810 |
Premium* |
|
|
Loxo Oncology, Inc. |
LOXO |
10% Owner |
2014-08-06 |
0 |
2014-08-06 |
1,789,420 |
Premium* |
|
|
Ardelyx Inc |
ARDX |
10% Owner |
2020-06-10 |
11,324 |
2020-06-10 |
0 |
Premium* |
|
|
Box Inc |
BOX |
10% Owner |
|
0 |
2015-01-28 |
0 |
Premium* |
|
|
Tracon Pharmaceuticals, Inc. |
TCON |
10% Owner |
2015-02-04 |
0 |
2016-11-29 |
2,758,039 |
Premium* |
|
|
Champions Biotechnology Inc |
CSBR |
10% Owner |
|
0 |
2015-03-11 |
18,750,000 |
Premium* |
|
|
Synlogic Inc |
SYBX |
10% Owner |
2015-10-05 |
0 |
2018-01-26 |
4,228,940 |
Premium* |
|
|
Avalo Therapeutics, Inc |
AVTX |
10% Owner |
2015-10-20 |
0 |
2015-10-20 |
594,245 |
Premium* |
|
|
Adaptimmune Therapeutics PLC |
ADAP |
10% Owner |
|
0 |
2018-09-07 |
82,978,668 |
Premium* |
|
|
Ra Pharmaceuticals, Inc. |
RARX |
10% Owner |
2016-10-31 |
0 |
2016-10-31 |
3,490,073 |
Premium* |
|
|
Mulesoft, Inc |
MULE |
10% Owner |
|
0 |
2018-05-01 |
0 |
Premium* |
|
|
Mersana Therapeutics, Inc. |
MRSN |
10% Owner |
2020-09-14 |
3,594 |
2020-09-14 |
0 |
Premium* |
|
|
Surface Oncology, Inc. |
SURF |
10% Owner |
2018-04-23 |
0 |
2018-04-23 |
3,312,877 |
Premium* |
|
|
Rhythm Pharmaceuticals, Inc. |
RYTM |
10% Owner |
2017-10-10 |
0 |
2017-10-10 |
4,909,956 |
Premium* |
|
|
Appian Corp |
APPN |
10% Owner |
2018-02-13 |
1,523 |
2018-02-13 |
0 |
Premium* |
|
|
Liquidia Technologies Inc |
LQDA |
10% Owner |
2018-07-30 |
0 |
2018-07-30 |
2,484,870 |
Premium* |
|
|
Oyster Point Pharma, Inc. |
OYST |
10% Owner |
|
0 |
2019-10-30 |
5,925,287 |
Premium* |
|
|
Cloudflare, Inc. |
NET |
10% Owner |
2020-11-11 |
203,454 |
2020-11-11 |
0 |
Premium* |
|
|
Sprout Social, Inc. |
SPT |
10% Owner |
2020-11-13 |
38,644 |
2020-11-13 |
0 |
Premium* |
|
|
Coursera, Inc. |
COUR |
10% Owner |
2021-05-19 |
70,394 |
2021-05-19 |
0 |
Premium* |
|
|
BuzzFeed, Inc |
BZFD |
Director, 10% Owner |
2023-12-03 |
222,847 |
2023-12-03 |
15,333,892 |
Premium* |
|
|
Sagimet Biosciences Inc. |
SGMT |
10% Owner |
2024-01-29 |
13,139 |
2024-01-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
217 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 9
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HEM |
Hemosense Inc |
10% Owner |
– – • |
2006-12-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,772,151 |
|
- |
|
| ARYX |
Aryx Therapeutics Inc |
10% Owner |
– – • |
2008-11-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,469,274 |
|
- |
|
| ECHO |
Echo Global Logistics Inc |
10% Owner |
– – • |
2009-10-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,420,219 |
|
- |
|
| GRPN |
Groupon, Inc. |
10% Owner |
– – • |
2011-11-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
87,184,956 |
|
- |
|
| HPTX |
Hyperion Therapeutics Inc |
10% Owner |
– – • |
2012-07-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,934 |
|
- |
|
| ILIU |
Interleukin Genetics Inc |
10% Owner |
– – • |
2013-05-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
15,429,122 |
|
- |
|
| ROKA |
Roka Bioscience, Inc. |
10% Owner |
– – • |
2014-07-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,734 |
|
- |
|
| BOX |
Box Inc |
10% Owner |
– – • |
2015-01-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
162,780 |
|
- |
|
| CSBR |
Champions Biotechnology I... |
10% Owner |
– – • |
2015-03-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
18,750,000 |
|
- |
|
| ADAP |
Adaptimmune Therapeutics ... |
10% Owner |
– – • |
2016-01-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
59,269,000 |
|
- |
|
| MULE |
Mulesoft, Inc |
10% Owner |
– – • |
2017-03-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
320,780 |
|
- |
|
| OYST |
Oyster Point Pharma, Inc. |
10% Owner |
– – • |
2019-10-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,925,287 |
|
- |
|
| COUR |
Coursera, Inc. |
10% Owner |
– – • |
2021-03-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
327,000 |
|
- |
|
| ECHO |
Echo Global Logistics Inc |
10% Owner |
– – • |
2012-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
97 |
97 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
10% Owner |
– – • |
2014-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
120 |
120 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
10% Owner |
– – • |
2015-05-07 |
4 |
D |
$46.00 |
$5,520 |
D/D |
(120) |
0 |
0 |
- |
|
| ECOM |
Channeladvisor Corp |
Director |
– • • |
2014-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
140 |
140 |
0 |
- |
|
| ECOM |
Channeladvisor Corp |
Director |
– • – |
2014-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
140 |
280 |
0 |
- |
|
| ECOM |
Channeladvisor Corp |
Director |
– • – |
2014-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
145 |
425 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
10% Owner |
– – • |
2014-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
241 |
241 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
10% Owner |
– – • |
2016-10-31 |
4 |
S |
$13.00 |
$5,655 |
I/I |
(435) |
80,223 |
0 |
- |
|
| TSRO |
Tesaro, Inc. |
10% Owner |
– – • |
2015-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
504 |
1,333 |
0 |
- |
|
| CRCM |
Care.com Inc |
10% Owner |
– – • |
2017-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
504 |
504 |
0 |
- |
|
| WDAY |
Workday, Inc. |
10% Owner |
– – • |
2013-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
559 |
1,730 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
10% Owner |
– – • |
2013-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
575 |
575 |
0 |
- |
|
217 Records found
|
|
Page 1 of 9 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
